NCT03029351 GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT03028766 WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT03022409 A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC). Status COMPLETED Phase PHASE1
NCT03022097 Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients Status COMPLETED Phase PHASE3
NCT03019549 A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin Status COMPLETED Phase PHASE1
NCT03019003 Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients Status COMPLETED Phase PHASE1
NCT03017183 Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy Status COMPLETED Phase NA
NCT03012321 Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03010436 Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study Status UNKNOWN Phase PHASE2
NCT03007329 Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE4
NCT03004105 MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC) Status WITHDRAWN Phase PHASE2
NCT03003962 Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02997501 T790M Plasma Testing Methodology Comparison and Clinical Validation Status COMPLETED Phase PHASE3
NCT02994511 Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials Status UNKNOWN Phase N/A
NCT02993991 Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity Status WITHDRAWN Phase PHASE1